Cargando…

Development of an Ingestible Expandable Capsule for Weight Loss

Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xingyu, Wu, Yeung, Liu, Chang, Chen, Kaiqi, Gregersen, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779746/
https://www.ncbi.nlm.nih.gov/pubmed/36554702
http://dx.doi.org/10.3390/ijerph192416821
_version_ 1784856685163053056
author Liu, Xingyu
Wu, Yeung
Liu, Chang
Chen, Kaiqi
Gregersen, Hans
author_facet Liu, Xingyu
Wu, Yeung
Liu, Chang
Chen, Kaiqi
Gregersen, Hans
author_sort Liu, Xingyu
collection PubMed
description Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membrane, and a gelatin capsule shell. It is designed to occupy volume in the stomach and reduce hunger sensation. The occupied volume is changeable over time, dependent on the number of ingested capsules and their degradation time. This will avoid gastric accommodation to constant volume devices as seen in the use of intragastric balloons. Several materials were tested. Collagen casing was selected as the membrane and corn silk was used to tie the membrane. Dried black fungus (Auricularia auricula) was the biological material that expanded most. However, synthesized cellulose-based hydrogel expanded more and was chosen as the optimal expandable core material. The hydrogel-based EndoXpand expanded 72 times after soaking in an acidic environment for 80 min. The corn silk ligations weakened and broke after 3 h. This resulted in release of the expanded material that was designed to easily pass the pylorus and travel down the intestine for digestion or excretion. In conclusion, this study provides design and in vitro proof-of-technology data for a potential groundbreaking approach. Further studies are needed in animal models and human phase I studies.
format Online
Article
Text
id pubmed-9779746
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97797462022-12-23 Development of an Ingestible Expandable Capsule for Weight Loss Liu, Xingyu Wu, Yeung Liu, Chang Chen, Kaiqi Gregersen, Hans Int J Environ Res Public Health Article Obesity has grown to epidemic proportions with 2.1 billion people being overweight worldwide. A food-grade expandable capsule named EndoXpand for the treatment of overweight people was designed and developed in this study. EndoXpand consists of an inner expandable material (core), an embracing membrane, and a gelatin capsule shell. It is designed to occupy volume in the stomach and reduce hunger sensation. The occupied volume is changeable over time, dependent on the number of ingested capsules and their degradation time. This will avoid gastric accommodation to constant volume devices as seen in the use of intragastric balloons. Several materials were tested. Collagen casing was selected as the membrane and corn silk was used to tie the membrane. Dried black fungus (Auricularia auricula) was the biological material that expanded most. However, synthesized cellulose-based hydrogel expanded more and was chosen as the optimal expandable core material. The hydrogel-based EndoXpand expanded 72 times after soaking in an acidic environment for 80 min. The corn silk ligations weakened and broke after 3 h. This resulted in release of the expanded material that was designed to easily pass the pylorus and travel down the intestine for digestion or excretion. In conclusion, this study provides design and in vitro proof-of-technology data for a potential groundbreaking approach. Further studies are needed in animal models and human phase I studies. MDPI 2022-12-15 /pmc/articles/PMC9779746/ /pubmed/36554702 http://dx.doi.org/10.3390/ijerph192416821 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Xingyu
Wu, Yeung
Liu, Chang
Chen, Kaiqi
Gregersen, Hans
Development of an Ingestible Expandable Capsule for Weight Loss
title Development of an Ingestible Expandable Capsule for Weight Loss
title_full Development of an Ingestible Expandable Capsule for Weight Loss
title_fullStr Development of an Ingestible Expandable Capsule for Weight Loss
title_full_unstemmed Development of an Ingestible Expandable Capsule for Weight Loss
title_short Development of an Ingestible Expandable Capsule for Weight Loss
title_sort development of an ingestible expandable capsule for weight loss
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779746/
https://www.ncbi.nlm.nih.gov/pubmed/36554702
http://dx.doi.org/10.3390/ijerph192416821
work_keys_str_mv AT liuxingyu developmentofaningestibleexpandablecapsuleforweightloss
AT wuyeung developmentofaningestibleexpandablecapsuleforweightloss
AT liuchang developmentofaningestibleexpandablecapsuleforweightloss
AT chenkaiqi developmentofaningestibleexpandablecapsuleforweightloss
AT gregersenhans developmentofaningestibleexpandablecapsuleforweightloss